Literature DB >> 32063789

Prophylactic ureteral catheter placement for minimally invasive colorectal surgery.

Katherine E Dowd1, Tommy O Muse1, Patrick S Lowry1, Rahila Essani1.   

Abstract

Ureteral catheter placement for identification of ureters during colorectal surgery has been a controversial subject with ill-defined indications. We present a case of ureteral catheter placement wherein the patient required readmission for renal failure with intervention under local anesthesia. This case highlights the importance of patient selection for catheter placement and clinical follow-up, as well as the need for prospective studies to determine the risk-benefit ratio of preoperative catheters.
Copyright © 2020 Baylor University Medical Center.

Entities:  

Keywords:  Colorectal surgery; ureteral catheter; ureteral identification

Year:  2019        PMID: 32063789      PMCID: PMC6988630          DOI: 10.1080/08998280.2019.1673876

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  15 in total

1.  Pharmacological Treatments for Acute Respiratory Distress Syndrome.

Authors:  Melissa Chudow; Michelle Carter; Mark Rumbak
Journal:  AACN Adv Crit Care       Date:  2015 Jul-Sep

2.  Inhaled Prostacyclin as Salvage Therapy for ARDS: Can We Find the Right Patient?

Authors:  Amy H Attaway; Catherine Myers; Shrey Velani; Robert Schilz
Journal:  Respir Care       Date:  2017-08       Impact factor: 2.258

3.  Prone positioning in severe acute respiratory distress syndrome.

Authors:  Claude Guérin; Jean Reignier; Jean-Christophe Richard; Pascal Beuret; Arnaud Gacouin; Thierry Boulain; Emmanuelle Mercier; Michel Badet; Alain Mercat; Olivier Baudin; Marc Clavel; Delphine Chatellier; Samir Jaber; Sylvène Rosselli; Jordi Mancebo; Michel Sirodot; Gilles Hilbert; Christian Bengler; Jack Richecoeur; Marc Gainnier; Frédérique Bayle; Gael Bourdin; Véronique Leray; Raphaele Girard; Loredana Baboi; Louis Ayzac
Journal:  N Engl J Med       Date:  2013-05-20       Impact factor: 91.245

Review 4.  The role of inhaled prostacyclin in treating acute respiratory distress syndrome.

Authors:  Randi J Searcy; James R Morales; Jason A Ferreira; Donald W Johnson
Journal:  Ther Adv Respir Dis       Date:  2015-08-20       Impact factor: 4.031

5.  Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.

Authors:  Marc Moss; David T Huang; Roy G Brower; Niall D Ferguson; Adit A Ginde; M N Gong; Colin K Grissom; Stephanie Gundel; Douglas Hayden; R Duncan Hite; Peter C Hou; Catherine L Hough; Theodore J Iwashyna; Akram Khan; Kathleen D Liu; Daniel Talmor; B Taylor Thompson; Christine A Ulysse; Donald M Yealy; Derek C Angus
Journal:  N Engl J Med       Date:  2019-05-19       Impact factor: 91.245

Review 6.  The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis.

Authors:  Brian M Fuller; Nicholas M Mohr; Lee Skrupky; Susan Fowler; Marin H Kollef; Christopher R Carpenter
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

7.  Predictors of outcome in 216 subjects with ARDS treated with inhaled epoprostenol.

Authors:  Jose Pacheco; Heather Arnold; Lee Skrupky; Peggy Watts; Scott T Micek; Marin H Kollef
Journal:  Respir Care       Date:  2014-08       Impact factor: 2.258

8.  Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.

Authors:  B Zwissler; G Kemming; O Habler; M Kleen; M Merkel; M Haller; J Briegel; M Welte; K Peter
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

Review 9.  A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome.

Authors:  Amy L Dzierba; Erik E Abel; Mitchell S Buckley; Ishaq Lat
Journal:  Pharmacotherapy       Date:  2014-03       Impact factor: 4.705

10.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.